Treatment algorithm for myelodysplastic syndrome in patients with intermediate (2), high, or very high risk profile, adapted from (5– 7) | Dark olive boxes: approved treatment in Europe; red boxes: participation recommended | Germing, U., Kobbe, G., Haas, R., & Gattermann, N. (2013). Myelodysplastic syndromes: diagnosis, prognosis, and treatment. Deutsches Arzteblatt International, 110(46), 783–790. https://doi.org/10.3238/arztebl.2013.0783

Leave a Reply